(Q43633624)

25 November 2017

Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia (English)

1 reference

25 November 2017

1 reference

1 reference

1 reference

D P Nicolau

1

1 reference

25 November 2017

J McNabb

2

1 reference

25 November 2017

M K Lacy

3

1 reference

25 November 2017

R Quintiliani

4

1 reference

25 November 2017

C H Nightingale

5

1 reference

25 November 2017

1 June 2001

1 reference

International Journal of Antimicrobial Agents

25 November 2017

1 reference

25 November 2017

17

1 reference

25 November 2017

497-504

1 reference

25 November 2017

6

1 reference

Epidemiology and control of nosocomial infections in adult intensive care units

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

Hospital-acquired pneumonia: epidemiology, etiology, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

Once-daily aminoglycoside therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

Experience with a once-daily aminoglycoside program administered to 2,184 adult patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

CDC definitions for nosocomial infections, 1988

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

The diagnosis and treatment challenges in nosocomial pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

"Continuous" vs. "discontinuous" therapy with penicillin; the effect of the interval between injections on therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

Continuous infusion of beta-lactam antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

A randomized study of carbenicillin plus cefamandole or tobramycin in the treatment of febrile episodes in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

A randomized trial of cefepime (BMY-28142) and ceftazidime for the treatment of pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

Ceftazidime monotherapy vs. ceftriaxone/tobramycin for serious hospital-acquired gram-negative infections. Antibiotic Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

Treatment of ventilator-associated pneumonia with piperacillin-tazobactam/amikacin versus ceftazidime/amikacin: a multicenter, randomized controlled trial. VAP Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

Continuous infusion of ceftazidime in febrile neutropenic patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

Low-dose continuous-infusion ceftazidime monotherapy in low-risk febrile neutropenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

A pilot study of the efficacy of constant-infusion ceftazidime in the treatment of endobronchial infections in adults with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

Intermittent and continuous ceftazidime infusion for critically ill trauma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

Continuous infusion of ceftazidime in cystic fibrosis patients during home treatment: clinical outcome, microbiology and pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infections

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

Continuous infusion of ceftazidime in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

Continuous infusion of ceftazidime in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

Cure of Pseudomonas aeruginosa infection in neutropenic patients by continuous infusion of ceftazidime

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

Intermittent bolus dosing of ceftazidime in critically ill patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

Continuous infusion ceftazidime in intensive care: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

Serum bactericidal activity of ceftazidime: continuous infusion versus intermittent injections.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900329-6

7 January 2021

10.1016/S0924-8579(01)00329-6

Identifiers

DOI

1 reference

25 November 2017

1 reference